Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00327834 · ClinicalTrials.gov registry record · Phase 4
Atomoxetine in the Treatment of Binge Eating Disorder
A Phase 4 study of Binge-Eating Disorder, sponsored by Lindner Center of HOPE.
- Completed
- Registry status
- Phase 4
- Development phase
- 1
- Study location
NCT00327834: Completed Phase 4 study of Binge-Eating Disorder, sponsored by Lindner Center of HOPE.
NCT00327834 is a Phase 4 study of Binge-Eating Disorder that has completed, run by Lindner Center of HOPE. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00327834, a Phase 4 study of Binge-Eating Disorder, has completed, sponsored by Lindner Center of HOPE.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1
- Study location
Study Summary
The specific aim of this study is to assess the efficacy and safety of atomoxetine compared with placebo in outpatients with binge eating disorder.
Conditions Studied
Interventions
- DRUG atomoxetine
Study Locations (1)
Ohio
- University of Cincinnati Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-05 |
| Est. Completion | 2007-03 |
| Phase | Phase 4 |
What the finished NCT00327834 record still lists
NCT00327834 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Binge-Eating Disorder appearing as the primary indexed condition, and to 1 intervention - of which atomoxetine is the first listed.
NCT00327834 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00327834 about?
NCT00327834 is a clinical study titled "Atomoxetine in the Treatment of Binge Eating Disorder". The specific aim of this study is to assess the efficacy and safety of atomoxetine compared with placebo in outpatients with binge eating disorder.
What is the current status of trial NCT00327834?
This trial is currently completed. It is a Phase 4 study. The study started on 2006-05. Estimated completion is 2007-03.
What conditions does trial NCT00327834 study?
This clinical trial studies the following conditions: Binge-Eating Disorder.
What interventions are being tested in trial NCT00327834?
The interventions under investigation include: atomoxetine (DRUG).
Who is sponsoring clinical trial NCT00327834?
This trial is sponsored by Lindner Center of HOPE, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00327834 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Binge-Eating Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder
RECRUITING · NA
-
Eating Disorders Genetics Initiative 2
RECRUITING
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
-
Project THINK: Trajectories of Health, Ingestive Behaviors, and Neurocognition in Kids
RECRUITING
-
Treating Binge Eating and Obesity Digitally in Black Women
RECRUITING · NA
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia